The OTC Monograph (non-prescription drug monograph) path cannot be judged solely by the product commonly known or by the “OTC” label. Enterprises need to check whether the active ingredient, agent type, adaptive condition, usage, warning phrases and labels meet applicable ad hoc conditions and to confirm, respectively, the registration of facilities, U.S. agent, Labeler Code, Drug Listing and the applicable costs.
Preliminary check order for the OTC Monograph Path
- Identify products as pharmaceutical products and verify intended uses, adaptive conditions, active ingredients and formulations.
- Finds the applicable OTC Monochorph Order, item by item, matching formulations, conditions of use and labelling requirements.
- Identify facilities for manufacturing, processing, packaging, labelling, etc., and their registration responsibilities.
- Combine the applicable subjects and information in Labeler Code, NDC format and Drug Listing.
- Verify whether or not it belongs to the OMUFA facility and the applicable costs by statutory definition, distinguishing the cost of the facility from the OOMOR application fee.
- Establish review arrangements for labelling, product information, facility information and annual maintenance.
Common Confusion
- OTC is a sales regulatory classification that does not automatically correspond to a monograph.
- Facilities registration, Drug Listing and NDC are different matters and cannot substitute for product path judgement.
- OMUFA costs are subject to a legal definition and not all pharmaceutical enterprises pay uniformly.
- The requirements are different from the OTC Monochorph path if the new drug application or other path is followed.
Official sources
Date of official source check: 2026-10-27. The conformity of specific products with the applicable obligations is confirmed by the product facts and by the FDA current rules.
View OTC Compliance ServiceView pricing and order online ↗
Continue reading and preparation
- FDA Unauthorized Drugs and NDC: Why not the listing record equals legal listing
- FDA Medicine Registration Process: Business Register, U.S. Agency, NDC and Drug Listing
Further consolidation of project information is availableOTC Monograph Path Support; The scope, processing cycles and costs are shown on the corresponding service page.